We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of ORTX yet.

ORTX Hedge Fund Activity: Q1 2024 in Review

0 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q1 2024, worth a combined $0 — down 100% from $122M a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of ORTX and 0 opened new positions — a net loss of 47 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deep Track Capital, exiting entirely with an estimated $33.6M sold.

  • 0 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q1 2024, down from 47 in Q4 2023.
  • Funds reported $0 of Orchard Therapeutics plc American Depositary Shares stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q1 2024 and 47 closed out, a net change of -47 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q1 2024 was Deep Track Capital, an estimated $33.6M sold.

Based on aggregated 13F filings for Q1 2024.